Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

E-ISSN： 1545-5017|62|6|1078-1080

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 1078-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study

JOURNAL OF ORTHOPAEDIC RESEARCH, Vol. 33, Iss. 8, 2015-08 ,pp. : 1205-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Giant cell tumor of bone revisited

By Mavrogenis Andreas F. Igoumenou Vasileios G. Megaloikonomos Panayiotis D. Panagopoulos Georgios N. Papagelopoulos Panayiotis J. Soucacos Panayotis N.

Sicot-J, Vol. 3, Iss. issue, 2017-09 ,pp. : 54-54

Edp Sciences

Access to resources Recommend Favorite

p63 as a prognostic marker for giant cell tumor of bone

By Yanagisawa Michiro

Upsala Journal of Medical Sciences, Vol. 118, Iss. 1, 2013-03 ,pp. : 23-28

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate Therapy is Effective in the Treatment of Sacral Giant Cell Tumor

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 702-704

Karger

Access to resources Recommend Favorite

Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone

Cytogenetic and Genome Research, Vol. 124, Iss. 2, 2009-05 ,pp. : 121-127

Karger

Access to resources Recommend Favorite